Affordable Insulin Now Act
The $35 cap survived for Medicare and fell three votes short for everyone with private insurance.
- BillH.R. 6833
- Congress117th Congress, 2021 to 2023
- SponsorAngie Craig (Democrat, MN)
- IntroducedFebruary 25, 2022
- Cause of deathStripped out
- Died inthe Senate
What it would have done
Capped out-of-pocket insulin costs at $35 a month for people on private insurance and Medicare Part D.
The path to law
The policy rode inside a larger bill and was removed before final passage, often on a procedural vote rather than a vote on the policy itself.
The votes
House, March 31, 2022. On passage (Roll no. 102).
Senate, August 7, 2022. Motion to waive the Byrd rule to keep the private-insurance cap in the Inflation Reduction Act.
Worth knowing
The Medicare half of this policy became law in the Inflation Reduction Act. The private-insurance half was struck after the parliamentarian ruled it out of order for reconciliation. Separately, the bill number H.R. 6833 was later reused as the vehicle for an unrelated stopgap spending law in September 2022, so Congress.gov lists H.R. 6833 as enacted. The insulin provisions were not part of that law.
The record
Last verified November 10, 2026.